Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Zolpidem improves dystonia in "Lubag" or X-linked dystonia-parkinsonism syndrome.

× No keyword cloud information.

12 in total

Review 1. Meige syndrome: what's in a name?

Authors: Mark S LeDoux
Journal: Parkinsonism Relat Disord Date: 2009-05-19 Impact factor: 4.891

2. Deep Brain Stimulation for DYT3 Dystonia.

Authors: Alexander Lehn; Caroline Airey; Sarah Olson; John D O'Sullivan; Richard Boyle
Journal: Mov Disord Clin Pract Date: 2014-04-10

Review 3. Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem.

Authors: Romy Hoque; Andrew L Chesson
Journal: J Clin Sleep Med Date: 2009-10-15 Impact factor: 4.062

Review 4. Treatment of Dystonia: Medications, Neurotoxins, Neuromodulation, and Rehabilitation.

Authors: Ian O Bledsoe; Aaron C Viser; Marta San Luciano
Journal: Neurotherapeutics Date: 2020-10-23 Impact factor: 7.620

5. Efficacy of zolpidem for dystonia: a study among different subtypes.

Authors: Yoshimichi Miyazaki; Wataru Sako; Kotaro Asanuma; Yuishin Izumi; Tetsuro Miki; Ryuji Kaji
Journal: Front Neurol Date: 2012-04-17 Impact factor: 4.003

Review 6. X-linked dystonia parkinsonism: clinical phenotype, genetics and therapeutics.

Authors: Raymond L Rosales
Journal: J Mov Disord Date: 2010-10-30

7. A case with improvement of blepharospasm by zolpidem.

Authors: Munkyung Sunwoo; Junghee Cho; Jun Hong Lee; Gyu Sik Kim; Jong Hun Kim; Sun-Ah Choi
Journal: J Mov Disord Date: 2011-04-30

Review 8. Medical treatment of dystonia.

Authors: Pichet Termsarasab; Thananan Thammongkolchai; Steven J Frucht
Journal: J Clin Mov Disord Date: 2016-12-19

Review 9. Clinicopathological Phenotype and Genetics of X-Linked Dystonia-Parkinsonism (XDP; DYT3; Lubag).

Authors: Toshitaka Kawarai; Ryoma Morigaki; Ryuji Kaji; Satoshi Goto
Journal: Brain Sci Date: 2017-06-26

Review 10. Can a Positive Allosteric Modulation of GABAergic Receptors Improve Motor Symptoms in Patients with Parkinson's Disease? The Potential Role of Zolpidem in the Treatment of Parkinson's Disease.

Authors: Antonio Daniele; Francesco Panza; Antonio Greco; Giancarlo Logroscino; Davide Seripa
Journal: Parkinsons Dis Date: 2016-05-17